Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

被引:136
作者
Buchheit, Kathleen M. [1 ,3 ]
Cahill, Katherine N. [1 ,3 ]
Katz, Howard R. [1 ,3 ]
Murphy, Katherine C. [3 ]
Feng, Chunli [3 ]
Lee-Sarwar, Kathleen [1 ]
Lai, Juying [3 ]
Bhattacharyya, Neil [2 ,4 ]
Israel, Elliot [1 ,5 ]
Boyce, Joshua A. [1 ,3 ]
Laidlaw, Tanya M. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Otolaryngol, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Pulm Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Aspirin-exacerbated respiratory disease; Samter triad; nasal polyps; thymic stromal lymphopoietin; prostaglandin D-2; cysteinyl leukotrienes; innate immunity; mast cells; eosinophils; INNATE LYMPHOID-CELLS; HUMAN EPITHELIAL-CELLS; MAST-CELL; EOSINOPHILIC INFLAMMATION; CYSTEINYL LEUKOTRIENES; CHRONIC RHINOSINUSITIS; ALLERGIC INFLAMMATION; CYTOKINE PRODUCTION; ASTHMATIC AIRWAYS; EXPRESSION;
D O I
10.1016/j.jaci.2015.10.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Prostaglandin (PG) D-2 is the dominant COX product of mast cells and is an effector of aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease (AERD). Objective: We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells to generate PGD(2) and facilitate tissue eosinophilia and nasal polyposis in patients with AERD. Methods: Urinary eicosanoid levels were measured in aspirin-tolerant control subjects and patients with AERD. Nasal polyp specimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR, Western blotting, and immunohistochemistry. Human cord blood-and peripheral blood-derived mast cells were stimulated with TSLP in vitro to assess PGD(2) generation. Results: Urinary levels of a stable PGD(2) metabolite (uPGD-M) were 2-fold higher in patients with AERD relative to those in control subjects and increased further during aspirin-induced reactions. Peak uPGD-Mlevels during aspirin reactions correlated with reductions in blood eosinophil counts and lung function and increases in nasal congestion. Mast cells sorted from nasal polyps expressed PGD(2) synthase (hematopoietic PGD(2) synthase) mRNA at higher levels than did eosinophils from the same tissue. Whole nasal polyp TSLP mRNA expression correlated strongly with mRNA encoding hematopoietic PGD(2) synthase (r = .75), the mast cell-specific marker carboxypeptidase A3 (r = .74), and uPGD-M (r=0.74). Levels of the cleaved active form of TSLP were increased in nasal polyps from patients with AERD relative to those in aspirin-tolerant control subjects. Recombinant TSLP induced PGD(2) generation by cultured human mast cells. Conclusions: Our study demonstrates that mast cell-derived PGD(2) is a major effector of type 2 immune responses driven by TSLP and suggests that dysregulation of this innate system contributes significantly to the pathophysiology of AERD.
引用
收藏
页码:1566 / +
页数:16
相关论文
共 54 条
[1]   Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells [J].
Allakhverdi, Zoulfia ;
Comeau, Michael R. ;
Jessup, Heidi K. ;
Yoon, Bo-Rin Park ;
Brewer, Avery ;
Chartier, Suzanne ;
Paquette, Nicole ;
Ziegler, Steven F. ;
Sarfati, Marika ;
Delespesse, Guy .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :253-258
[2]   CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation [J].
Allakhverdi, Zoulfia ;
Comeau, Michael R. ;
Smith, Dirk E. ;
Toy, Dean ;
Endam, Leandra Mfuna ;
Desrosiers, Martin ;
Liu, Yong-Jun ;
Howie, Karen J. ;
Denburg, Judah A. ;
Gauvreau, Gail M. ;
Delespesse, Guy .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) :472-478
[3]   A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge [J].
Bochenek, G ;
Nagraba, K ;
Nizankowska, E ;
Szczeklik, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (04) :743-749
[4]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[5]   Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease [J].
Cahill, Katherine N. ;
Bensko, Jillian C. ;
Boyce, Joshua A. ;
Laidlaw, Tanya M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (01) :245-252
[6]   IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation [J].
Ellen B Cook ;
James L Stahl ;
Elizabeth A Schwantes ;
Kristen E Fox ;
Sameer K Mathur .
Clinical and Molecular Allergy, 10 (1)
[7]   Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses [J].
Corrigan, Chris J. ;
Wang, Wei ;
Meng, Qiu ;
Fang, Cailong ;
Eid, Ghada ;
Caballero, M. Rosario ;
Lv, Ze ;
An, Yunqing ;
Wang, Yui-Hsi ;
Liu, Yong-Jun ;
Kay, A. Barry ;
Lee, Tak H. ;
Ying, Sun .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (01) :116-124
[8]   DIRECT EVIDENCE FOR A ROLE OF THE MAST-CELL IN THE NASAL RESPONSE TO ASPIRIN IN ASPIRIN-SENSITIVE ASTHMA [J].
FISCHER, AR ;
ROSENBERG, MA ;
LILLY, CM ;
CALLERY, JC ;
RUBIN, P ;
COHN, J ;
WHITE, MV ;
IGARASHI, Y ;
KALINER, MA ;
DRAZEN, JM ;
ISRAEL, E .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (06) :1046-1056
[9]   Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses [J].
Gauvreau, Gail M. ;
O'Byrne, Paul M. ;
Boulet, Louis-Philippe ;
Wang, Ying ;
Cockcroft, Donald ;
Bigler, Jeannette ;
FitzGerald, J. Mark ;
Boedigheimer, Michael ;
Davis, Beth E. ;
Dias, Clapton ;
Gorski, Kevin S. ;
Smith, Lynn ;
Bautista, Edgar ;
Comeau, Michael R. ;
Leigh, Richard ;
Parnes, Jane R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2102-2110
[10]   IL-33 promotes airway remodeling and is a marker of asthma disease severity [J].
Guo, Zhi ;
Wu, Jinxiang ;
Zhao, Jiping ;
Liu, Fen ;
Chen, Yingjian ;
Bi, Liquan ;
Liu, Shuying ;
Dong, Liang .
JOURNAL OF ASTHMA, 2014, 51 (08) :863-869